Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:10/5/2009

VIENNA, Va., Oct. 5 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI Corporation (NYSE AMEX: CVM) to its shareholders:

Dear Fellow Shareholders:

After FDA had communicated several weeks ago that we could proceed with our initial clinical trial with our proposed H1N1 treatment for hospitalized H1N1 patients, we have received many questions with regards to H1N1. With this in mind, we have asked one of our outside collaborators, Ken S. Rosenthal, Ph.D., Professor, Microbiology, Immunology and Biochemistry, Northeastern Ohio Universities Colleges of Medicine and Pharmacology, to help explain in layman's terms the course of the H1N1 disease and why it can be so dangerous. Dr. Rosenthal also has provided an explanation of how CEL-SCI's investigational H1N1 treatment may help in very sick hospitalized patients. Dr. Rosenthal explains:

Background information on influenza and H1N1 influenza:

Influenza infection could have very mild consequences or cause very severe disease. At the least, it may seem like a severe cold and at the worst, it can be life-threatening. Influenza is a respiratory virus spread in the tiny water droplets that we release every time we exhale and then are inhaled by another person. These droplets enter the mouth and nose and travel down the throat and into the lungs. When influenza infects a person's lungs, there are three destructive components working together to cause disease: the virus's ability to kill the lung cells; the immune system's inflammatory reactions that kill influenza infected cells; and bacterial infections that establish themselves in the diseased environment.

Influenza virus infects the ciliated epithelial cells of the respiratory tract that help keep foreign material out of the lungs. The virus attaches to these cells through specific sugar molecules, called sialic acids, on the proteins and lipids on t
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
2. CEL-SCI Expands H1N1 Flu Virus Work
3. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
4. CEL-SCI Posts New Corporate Presentation to Website
5. CEL-SCI Corporation Releases Letter to Shareholders
6. CEL-SCI Corporation Releases Letter to Shareholders
7. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
8. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
9. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Corporation Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a ... diseases and cholesterol gallstones, announced today that the ... approved its request for Fast Track Designation of ... Non-Alcoholic Steato-Hepatitis, or NASH.  FDA ...
(Date:9/23/2014)... 2014  MEDIMETRIKS PHARMACEUTICALS today announced that ... have been elected to Medimetriks, Board of Directors ... who will serve on Medimetriks, Audit Committee, brings ... the Company.  Mr. Lary is currently Managing Director, ... institutional investment firm.  Mr. Lary is responsible for ...
(Date:9/23/2014)... 23, 2014  Vesselon, Inc. today announced the appointment ... effective September 15, 2014. Dr. Raths, appointment follows Vesselon,s ... agent to market a private preferred Series A round ... treatment. "Jurgen,s deep experience across multiple functional ... asset to Vesselon as we develop our device that ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 2Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 3Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3
(Date:9/23/2014)... CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF OPIOIDS IN ... , The National Institutes of Health is convening a ... evidence on the long-term effectiveness and potential risks of ... the nation,s top experts in the field of pain ... as key NIH scientists who focus on pain related ...
(Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- Both drinking ... risk factors for alcohol abuse by high school students, ... a survey of high school students who drink, could ... those who already drink, to stop them from becoming ... distinguish between age of first alcohol use and progression ...
(Date:9/23/2014)... York, NY (PRWEB) September 23, 2014 ... congregation on Manhattan’s Upper West Side that embodies ... host Inhabiting Eden: Christians, Scripture and the Ecological ... Tull, A. B. Rhodes Professor Emerita of Old ... the Bible for ancient wisdom that lends insight ...
(Date:9/23/2014)... the benefits of preventing a reduction in the ... released today by the American College of Physicians ... the Medicaid Primary Care Pay Parity Program: Unless ... Primary Care Will Expire," explains why it is ... and pediatricians (and their related subspecialists), family physicians, ...
Breaking Medicine News(10 mins):Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3
... , BUFFALO, N.Y., Dec. 3 To help children ... prevent contracting all forms of influenza, a new animated health education ... , The DVD was created by the Erie Niagara Area Health ... Center (AHEC) program with offices in 40 states. , The U.S. ...
... , , TAMPA, Fla., Dec. 3 ... suffer from crippling back and neck pain are putting ... from chronic spinal disorders through minimally-invasive endoscopic surgery is ... Spine Institute (LSI). With surgical facilities in Tampa, ...
... , WASHINGTON, Dec. 3 The Redwood ... who are struggling financially and worried about paying for their medicines. ... has helped more than 6 million patients find programs providing prescription ... Prescription Assistance has access to information on more than 475 patient ...
... (BBRI) and the University of Pennsylvania have found that ... green tea component EGCG, can prevent and destroy a ... the primary culprits in fatal brain disorders such as ... in the current issue of Nature Chemical Biology ...
... , WEDNESDAY, Dec. 2 (HealthDay News) -- The human papillomavirus ... six years, new research has found. , The vaccine guards ... commonly associated with cervical cancer. , The study looked at ... cervical profile and no evidence of HPV infection at the ...
... it cut risk factors linked to diabetes, cardiovascular trouble, ... even for just a couple of months, can significantly ... dangerous cluster of heart disease risk factors -- years ... in the journal Diabetes . , In women ...
Cached Medicine News:Health News:New Animated DVD Helps Children to Better Understand and Prevent Contracting the Flu 2Health News:Give the Gift of Relief for the New Year 2Health News:Green tea chemical combined with another may hold promise for treatment of brain disorders 2Health News:Cervarix Proves Effective Against HPV for Over 6 Years 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3
The Auto Suture DFS stapler is a disposable fascia stapler. The stapler places one staple each time the instrument handles are activated. The staples first penetrate the fascia and are then formed, t...
... PROXIMATE RH skin stapler is a full-feature ... assembly., ,PROXIMATE RH has improved visibility ... with a ratchet mechanism for easier staple ... sterile, single patient use instrument designed to ...
... PROXIMATE Reloadable Linear Staplers deliver two staggered rows ... sizes. They may be reloaded up to three ... models fire heavy wire staples for thick tissue. ... not interchangeable., ,Benefits include: , Parallel jaw ...
... Single Use Loading Units for ... (Single Use Reloadable Staplers with ... Suture™ TA™ Reloadable staplers has ... and thoracic surgical procedures for ...
Medicine Products: